MedTrace Logo

It´s Up To You: Update and Digitalization of a Universal School-based Prevention Intervention for Drug Initiation and Use

NCT05950074 · Status: ACTIVE_NOT_RECRUITING · Phase: NA · Type: INTERVENTIONAL · Enrollment: 1000

Last updated 2024-03-08

No results posted yet for this study

Summary

This non-randomized cluster-controlled trial examines the effectiveness of the digitalized and updated version of the It´s Up To You - program, a universal school-based prevention intervention for drug initiation and use targeting youth aged between 12 and 17 years.

Conditions

  • Substance Use
  • Behavior, Addictive
  • Smoking Behaviors
  • Alcohol Drinking
  • Illicit Drug Use

Interventions

BEHAVIORAL

"It´s Up To You" program

The main goal of this program is to prevent substance use and engagement in addictive behaviors through enabling teenagers to make informed and responsible decisions. It seeks to support students in the anticipation of realistic choice situations and problems typically affecting this age group. It is based on social influences, considering the peer group influences (peer pressure) and the affective and cognitive factors that intervene at the time of decision-making and problem-resolution. This program is intended to be delivered by trained teachers in six sessions through six different modules.

Sponsors & Collaborators

  • University of Santiago de Compostela

    collaborator OTHER

  • University of Oviedo

    collaborator OTHER

  • University of the Balearic Islands

    collaborator OTHER

  • Instituto Europeo de Estudios en Prevención

    lead OTHER

Principal Investigators

  • Montserrat Juan, PhD · Instituto Europeo de Estudios en Prevención

Study Design

Allocation
NON_RANDOMIZED
Purpose
PREVENTION
Masking
SINGLE
Model
PARALLEL

Eligibility

Min Age
12 Years
Max Age
17 Years
Sex
ALL
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2023-10-01
Primary Completion
2024-04-30
Completion
2024-07-31

Countries

  • Spain

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT05950074 on ClinicalTrials.gov